Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program

Terminated

• Conditions: Postpartum Uterine Bleeding

• Registration Number: NCT01198652
• Lead Sponsor: Glenveigh Medical

Brief Summary

This is an open, post-marketing surveillance study obtaining data retrospectively on 300 women, of any age, treated with the BD-OTS for postpartum uterine bleeding.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09
• Study First Submitted: 2010-09-09
• Study First Submitted QC: 2010-09-09
• Study First Posted: 2010-09-10
• Primary Completion: 2012-10
• Study Completion: 2012-10
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-04
• Last Update Posted: 2013-03-05

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• Treatment with the BD-OTS device

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (11)

Banner Good Samaritan Medical Center; 🇺🇸 Phoenix, Arizona, United States

University of Cincinnati; 🇺🇸 Cincinnati, Ohio, United States

Monmouth Medical Center; 🇺🇸 Long Branch, New Jersey, United States

Orlando Health; 🇺🇸 Orlando, Florida, United States

Toledo Hospital; 🇺🇸 Toledo, Ohio, United States

Erlanger; 🇺🇸 Chattanooga, Tennessee, United States

UHS - Wilson Medical Center; 🇺🇸 Johnson City, New York, United States

Presbyterian/St. Luke's Medical Center; 🇺🇸 Denver, Colorado, United States

North Austin Medical Center - St. David's Women's Center of Texas; 🇺🇸 Austin, Texas, United States

St. David's Medical Center; 🇺🇸 Austin, Texas, United States

Medical University of South Carolina; 🇺🇸 Charleston, South Carolina, United States